Schreiner MediPharm will showcase new products at InnoPack, as part of the CPhI Worldwide in Madrid from 13-15 October in hall 4, booth 4B63.
A special highlight is the latest development of Flexi-Cap, an innovative security solution which irreversibly shows that a primary container has been opened, and prevents illegal reuse and filling of empty containers with counterfeit substances.
The concept was expanded to include coloured film caps to indicate medication and strength for easy recognition by healthcare practitioners to aid in avoiding medication errors.
Counterfeiters search for empty original containers in waste containers to refill them and illegally sell them as originals. Schreiner MediPharm’s Flexi-Cap makes this impossible as the security concept is based on an innovative combination of label and cap.
The film cap is first put over the closed container, then the label is applied without covering the peel-open tab on the opening strip.
Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the reset of the cap destroys the label and eliminates the possibility of illegal, unnoticed reuse.
Due to the novel coloured film caps, Flexi-Cap can also be used to prevent medication errors. Colour marking allows physicians and nurses to instantly verify they are handling the right product and dosage.
The cap’s transparent film material is printed using various easily differentiated colours. Pharmaceutical manufacturers can design caps to meet specific requirements.
Since the solution leaves ample space for customer-specific designs, they can also include branding components.
Flexi-Cap allows flexible use with different container types, forms and sizes. Unlike shrink-wrap solutions, the label construction can be applied without using heat, making it suitable for temperature-sensitive medicines.
The top of Flexi-Cap allows space for bar code printing or NFC chip integration for electronic tracking. In addition, important user information can be communicated and patient compliance documented.